Evidence map›Paper›PMID 9334431›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1997

Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.

B Bontempi, F R Sharp

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 122 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A highly DNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  5. Article
  6. Review
  7. Dopamine and addiction: what have we learned from 40 years of research.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
  8. Heteromers of μ opioid and dopamine DBritish journal of pharmacology · 2017
    Article
  9. Review
  10. Article
  11. GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

B BontempiDepartment of Neurology (V127), University of California at San Francisco and Department of Veterans Affairs Medical Center, San Francisco, California 94121, USA.
F R Sharp
San Francisco VA Medical Center · US

Funding

MARKERS OF CNS INJURYR01NS028167 · NINDS · UNIVERSITY OF CINCINNATI · PI SHARP, FRANK R · 1990 to 2006
$1.9M
Promotion of Angiogenesis in Lung Cancer by MIFR01CA094121 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ARENBERG, DOUGLAS · 2002 to 2010
$1.9M
NCI NIH HHS R01 CA094121NINDS NIH HHS NS28167NINDS NIH HHS R01 NS028167
6 · The paper itself

Abstract

To characterize how systemic morphine induces Fos protein in dorsomedial striatum and nucleus accumbens (NAc), we examined the role of receptors in striatum, substantia nigra (SN), and ventral tegmental area (VTA). Morphine injected into medial SN or into VTA of awake rats induced Fos in neurons in ipsilateral dorsomedial striatum and NAc. Morphine injected into lateral SN induced Fos in dorsolateral striatum and globus pallidus. The morphine infusions produced contralateral turning that was most prominent after lateral SN injections. Intranigral injections of [D-Ala2, N-Me-Phe4, Gly-ol5]-enkephalin (DAMGO), a mu opioid receptor agonist, and of bicuculline, a GABAA receptor antagonist, induced Fos in ipsilateral striatum. Fos induction in dorsomedial striatum produced by systemic administration of morphine was blocked by (1) SN and VTA injections of the mu1 opioid antagonist naloxonazine and (2) striatal injections of either MK 801, an NMDA glutamate receptor antagonist, or SCH 23390, a D1 dopamine receptor antagonist. Fos induction in dorsomedial striatum and NAc after systemic administration of morphine seems to be mediated by dopamine neurons in medial SN and VTA that project to medial striatum and NAc, respectively. Systemic morphine is proposed to act on mu opioid receptors located on GABAergic interneurons in medial SN and VTA. Inhibition of these GABA interneurons disinhibits medial SN and VTA dopamine neurons, producing dopamine release in medial striatum and NAc. This activates D1 dopamine receptors and coupled with the coactivation of NMDA receptors possibly from cortical glutamate input induces Fos in striatal and NAc neurons. The modulation of target gene expression by Fos could influence addictive behavioral responses to opiates.

Indexed as

Genes, fosAfferent PathwaysAnalgesics, OpioidAnimalsBehavior, AnimalBenzazepinesBicucullineCorpus StriatumDizocilpine MaleateDopamine AntagonistsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-EnkephalinsExcitatory Amino Acid AntagonistsFemaleGABA AntagonistsGene Expression RegulationAnalgesics, OpioidBenzazepinesBicucullineDizocilpine MaleateDopamine AntagonistsEnkephalin, Ala(2)-MePhe(4)-Gly(5)-EnkephalinsExcitatory Amino Acid AntagonistsGABA AntagonistsMorphinenaloxonazineNaloxoneNerve Tissue ProteinsProto-Oncogene Proteins c-fosReceptors, Dopamine D1Receptors, GABA-AReceptors, N-Methyl-D-AspartateReceptors, Opioid, mu

Identifiers

PMID9334431
PMCPMC6573751
OpenAlexW1957364299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.